Revance Therapeutics Inc. buy BiotechBee
Start price
03.01.23
/
70%
€17.50
Target price
31.12.25
€30.00
Performance (%)
76.00%
End price
05.05.23
€30.80
Summary
This prediction ended on 05.05.23 with a price of €30.80. The BUY prediction by BiotechBee for Revance Therapeutics Inc. saw massive gains of 76.00%. BiotechBee has 70% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Revance Therapeutics Inc. | - | - | - |
iShares Core DAX® | 1.164% | 1.549% | 24.351% |
iShares Nasdaq 100 | 0.118% | 0.969% | 28.865% |
iShares Nikkei 225® | 1.124% | -1.120% | 17.443% |
iShares S&P 500 | 0.479% | 1.068% | 28.585% |
According to BiotechBee what are the pros and cons of Revance Therapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Revance Therapeutics Inc. diskutieren
Buy mit Kursziel 30,0
In the thread Trading Revance Therapeutics Inc.
Buy beendet